Susanne Bechtold-Dalla Pozza
Overview
Explore the profile of Susanne Bechtold-Dalla Pozza including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
281
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Meyhofer S, Hammersen J, Schmid S, Khodaverdi S, Dafsari R, Otfried-Schwab K, et al.
Diabetes Care
. 2024 Sep;
47(12):e106-e108.
PMID: 39331038
No abstract available.
2.
Pozza S, Lemster S, Herzig N, Vill K, Dubinski I, Hohenfellner K
J Bone Miner Res
. 2024 Jun;
39(8):1094-1102.
PMID: 38864569
Nephropathic cystinosis is an orphan autosomal recessive lysosomal storage disease characterized by a deficiency of cystinosin, a cystine transporter protein, leading to tissue damage, primarily in the kidney and cornea....
3.
Dubinski I, Pozza S, Debor B, Nowotny H, Reisch N, Tschaidse L, et al.
Eur J Endocrinol
. 2024 Apr;
190(5):L5-L6.
PMID: 38630639
No abstract available.
4.
Dubinski I, Pozza S, Bidlingmaier M, Hawley J, Keevil B, Kunz S, et al.
J Pediatr Endocrinol Metab
. 2024 Apr;
37(5):419-424.
PMID: 38557593
Objectives: The most suitable biochemical markers for therapy adjustment in patients with congenital adrenal hyperplasia are controversial. 11-Oxygenated androgens are a promising new approach. The objective of this study was...
5.
Debor B, Pozza S, Reisch N, Schmidt H, Dubinski I
J Pediatr Endocrinol Metab
. 2023 Aug;
36(10):930-940.
PMID: 37650550
Objectives: Children with classical congenital adrenal hyperplasia (CAH) require glucocorticoid (GC) substitution due to impaired cortisol synthesis. To avoid over- or undertreatment, one has to consider auxology as well as...
6.
Dubinski I, Pozza S, Debor B, Nowotny H, Reisch N, Tschaidse L, et al.
J Clin Res Pediatr Endocrinol
. 2023 May;
15(4):380-389.
PMID: 37218136
Objective: Patients with congenital adrenal hyperplasia (CAH) require lifelong therapy with glucocorticoids to suppress androgen excess and substitute for deficient cortisol. An important aspect of care is the prevention of...
7.
Stahl-Pehe A, Kamrath C, Prinz N, Kapellen T, Menzel U, Kordonouri O, et al.
J Diabetes
. 2022 Dec;
14(12):840-850.
PMID: 36515004
Background: To provide estimates of the nationwide prevalence of type 1 diabetes (T1D) and type 2 diabetes (T2D) in individuals younger than 20 years of age in Germany from 2002...
8.
Dubinski I, Pozza S, Schmidt H
J Pediatr Endocrinol Metab
. 2022 Oct;
35(12):1544-1546.
PMID: 36240057
We present a 9-year-old boy with diabetes insipidus. The boy is treated with desmopressin (DDAVP) therapy. Under this therapy, the drinking quantity and the laboratory parameters were normal. No nocturia...
9.
Reiter U, Eckert A, Dunstheimer D, Pozza S, Lullwitz C, Golembowski S, et al.
Pediatr Diabetes
. 2022 Jan;
23(3):362-369.
PMID: 35064955
Objective: To study diabetic cataract in type 1 diabetes in a large pediatric cohort. Methods: The 92,633 patients aged 0.5-21 years from German/Austrian multicenter diabetes registry (DPV) were analyzed. The...
10.
Hackl L, Bonfig W, Pozza S, Lanzinger S, Treptau N, Raile K, et al.
Pediatr Diabetes
. 2021 Nov;
23(1):64-72.
PMID: 34779099
Background: Treatment of patients with type 1 diabetes requires experience and a specific infrastructure. Therefore, center size might influence outcome in diabetes treatment. Objective: To analyze the influence of center...